Codexis (CDXS) Debt/Equity Ratio: History & Chart

Codexis, Inc.(CDXS)

Biotechnology · Redwood City, CA

$1.37-0.02 (-1.42%)

Delayed quote: Oct 6, 2026, 3:24 PM EDT

About Codexis, Inc.

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.

Redwood City, CA

146 employees

www.codexis.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Alison Moore

View full financials

CDXS Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

2.20

DEBT TO EQUITY RATIO AVG TTM

1.67

DEBT TO EQUITY RATIO AVG 3Y

1.00

DEBT TO EQUITY RATIO AVG 5Y

0.72

DEBT TO EQUITY RATIO AVG 10Y

0.29

DEBT TO EQUITY RATIO AVG 15Y

0.14

DEBT TO EQUITY RATIO AVG 20Y

0.11

CURRENT VS TTM AVG

+31.76%

CURRENT VS 3Y AVG

+120.36%

CURRENT VS 5Y AVG

+206.71%

CURRENT VS 10Y AVG

+668.19%

CURRENT VS 15Y AVG

+1514.25%

CURRENT VS 20Y AVG

+1934.37%

SECTOR MEDIAN · HEALTHCARE

0.11

median of 774 covered companies

CURRENT VS SECTOR MEDIAN

+1902.19%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Codexis, Inc. (CDXS)	$147.39M	2.20	1.67	1.00	0.72
ALX Oncology Holdings Inc. (ALXO)vs ›	$148.69M	0.07	0.17	0.12	0.08
Anavex Life Sciences Corp. (AVXL)vs ›	$147.81M	0.00	0.00	0.00	0.00
Cardiol Therapeutics Inc. (CRDL)vs ›	$149.85M	0.00	0.01	0.01	0.01
Voyager Therapeutics, Inc. (VYGR)vs ›	$147.13M	0.21	0.17	0.21	0.27
Acumen Pharmaceuticals, Inc. (ABOS)vs ›	$146.98M	0.55	0.30	0.18	0.12
NervGen Pharma Corp. Common stock (NGEN)vs ›	$146.71M	0.00	0.02	0.02	0.01
Veraxa Biotech Holding AG (VRXA)vs ›	$149.89M	N/A	N/A	N/A	N/A
Protara Therapeutics, Inc. (TARA)vs ›	$145.85M	0.02	0.03	0.05	0.04
Korsana Biosciences, Inc. (KRSA)vs ›	$144.47M	0.00	0.00	0.00	0.13

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Codexis, Inc. (CDXS)

$147.39M

2.20

1.67

1.00

0.72

ALX Oncology Holdings Inc. (ALXO)vs ›

$148.69M

0.07

0.17

0.12

0.08

Anavex Life Sciences Corp. (AVXL)vs ›

$147.81M

0.00

Cardiol Therapeutics Inc. (CRDL)vs ›

$149.85M

0.00

0.01

Voyager Therapeutics, Inc. (VYGR)vs ›

$147.13M

0.21

0.17

0.21

0.27

Acumen Pharmaceuticals, Inc. (ABOS)vs ›

$146.98M

0.55

0.30

0.18

0.12

NervGen Pharma Corp. Common stock (NGEN)vs ›

$146.71M

0.00

0.02

0.01

Veraxa Biotech Holding AG (VRXA)vs ›

$149.89M

N/A

Protara Therapeutics, Inc. (TARA)vs ›

$145.85M

0.02

0.03

0.05

0.04

Korsana Biosciences, Inc. (KRSA)vs ›

$144.47M

0.00

0.13

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Codexis, Inc. (CDXS)?

The debt to equity ratio for CDXS stock is 2.20.

Is Codexis, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 2.20 is 207% above its 5-year average of 0.72, near the high end of its 5-year range (0.14–2.20).

What is the TTM average debt to equity ratio for Codexis, Inc. (CDXS)?

The TTM average debt to equity ratio for CDXS stock is 1.67.

What is the 3Y average debt to equity ratio for Codexis, Inc. (CDXS)?

The 3Y average debt to equity ratio for CDXS stock is 1.00.

What is the 5Y average debt to equity ratio for Codexis, Inc. (CDXS)?

The 5Y average debt to equity ratio for CDXS stock is 0.72.

What is the 10Y average debt to equity ratio for Codexis, Inc. (CDXS)?

The 10Y average debt to equity ratio for CDXS stock is 0.29.

What is the 15Y average debt to equity ratio for Codexis, Inc. (CDXS)?

The 15Y average debt to equity ratio for CDXS stock is 0.14.

What is the 20Y average debt to equity ratio for Codexis, Inc. (CDXS)?

The 20Y average debt to equity ratio for CDXS stock is 0.11.

DATE	DEBT TO EQUITY RATIO
2026-06-30	2.20
2026-03-31	1.69
2025-12-31	1.45
2025-09-30	1.78
2025-06-30	1.24
2025-03-31	1.20
2024-12-31	0.89
2024-09-30	0.57
2024-06-30	0.69
2024-03-31	0.55
2023-12-31	0.19
2023-09-30	0.22
2023-06-30	0.33
2023-03-31	0.34
2022-12-31	0.30
2022-09-30	0.29
2022-06-30	0.29
2022-03-31	0.30
2021-12-31	0.29
2021-09-30	0.14
2021-06-30	0.15
2021-03-31	0.15
2020-12-31	0.15
2020-09-30	0.28
2020-06-30	0.28
2020-03-31	0.26
2019-12-31	0.25
2019-09-30	0.26
2019-06-30	0.27
2019-03-31	0.54
2018-12-31	0.01
2018-09-30	0.00
2018-06-30	0.00
2018-03-31	0.02
2017-12-31	0.01
2017-09-30	0.02
2017-06-30	0.01
2017-03-31	0.02
2016-12-31	0.02
2016-09-30	0.04
2016-06-30	0.06
2016-03-31	0.07
2015-12-31	0.02
2015-09-30	0.00
2015-06-30	0.00
2015-03-31	0.00
2014-12-31	0.00
2014-09-30	0.00
2014-06-30	0.00
2014-03-31	0.00
2013-12-31	0.00
2013-09-30	0.00
2013-06-30	0.00
2013-03-31	0.00
2012-12-31	0.00
2012-09-30	0.00
2012-06-30	0.00
2012-03-31	0.00
2011-12-31	0.00
2011-09-30	0.00
2011-06-30	0.00
2011-03-31	0.00
2010-12-31	0.00
2010-09-30	0.04
2010-06-30	0.05
2010-03-31	-0.05
2009-12-31	0.08
2009-09-30	-0.07
2009-06-30	0.00
2009-03-31	0.00
2008-12-31	-0.11
2008-03-31	-0.17
2007-03-31	0.00

DATE

DEBT TO EQUITY RATIO

2026-06-30

2.20

2026-03-31

1.69

2025-12-31

1.45

2025-09-30

1.78

2025-06-30

1.24

2025-03-31

1.20

2024-12-31

0.89

2024-09-30

0.57

2024-06-30

0.69

2024-03-31

0.55

2023-12-31

0.19

2023-09-30

0.22

2023-06-30

0.33

2023-03-31

0.34

2022-12-31

0.30

2022-09-30

0.29

2022-06-30

0.29

2022-03-31

0.30

2021-12-31

0.29

2021-09-30

0.14

2021-06-30

0.15

2021-03-31

0.15

2020-12-31

0.15

2020-09-30

0.28

2020-06-30

0.28

2020-03-31

0.26

2019-12-31

0.25

2019-09-30

0.26

2019-06-30

0.27

2019-03-31

0.54

2018-12-31

0.01

2018-09-30

0.00

2018-06-30

0.00

2018-03-31

0.02

2017-12-31

0.01

2017-09-30

0.02

2017-06-30

0.01

2017-03-31

0.02

2016-12-31

0.02

2016-09-30

0.04

2016-06-30

0.06

2016-03-31

0.07

2015-12-31

0.02

2015-09-30

0.00

2015-06-30

0.00

2015-03-31

0.00

2014-12-31

0.00

2014-09-30

0.00

2014-06-30

0.00

2014-03-31

0.00

2013-12-31

0.00

2013-09-30

0.00

2013-06-30

0.00

2013-03-31

0.00

2012-12-31

0.00

2012-09-30

0.00

2012-06-30

0.00

2012-03-31

0.00

2011-12-31

0.00

2011-09-30

0.00

2011-06-30

0.00

2011-03-31

0.00

2010-12-31

0.00

2010-09-30

0.04

2010-06-30

0.05

2010-03-31

-0.05

2009-12-31

0.08

2009-09-30

-0.07

2009-06-30

0.00

2009-03-31

0.00

2008-12-31

-0.11

2008-03-31

-0.17

2007-03-31

0.00

Debt to Equity Ratio: 2.20

CDXS Debt to Equity Ratio

CDXS Average Debt to Equity Ratio Chart

CDXS Current vs Average Debt to Equity Ratio Chart

CDXS Debt to Equity Ratio Metrics

CDXS Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

CDXS Debt to Equity Ratio History

Related Metrics